How to Know if Tirzepatide Could Be Right for You: Tirzepatide is believed to be potentially better at assisting weight loss than semaglutide
The British Menopause Society confirms there is no official contraindication to using GLP-1 receptor agonists concurrently with hormone replacement therapy
At 40 weeks, tirzepatide 5 mg, 10 mg, and 15 mg produced greater HbA1C reductions and greater weight loss than semaglutide 1 mg
Using the available research as a reference, the recommended starting dose of semaglutide is 0.25mg/weekly, and it should be increased every four weeks up to a maximum of 2.4mg/weekly [25, 26]
Converting other common unit amounts to milligrams Understanding the 10-unit conversion is great
Whone A, Luz M, Boca M, et al